Journal of clinical and experimental hematopathology : JCEHHumansImmunotherapyAdoptiveLymphomaLarge B-Cell
CRS and ICANS in CAR T-cell therapy for large B-cell lymphoma.
Hideki Goto
Published: 202510.3960/jslrt.25072
Abstract
Chimeric antigen receptor T-cell (CAR T-cell) therapy has become an established treatment option for relapsed or refractory large B-cell lymphoma, offering durable remission in some previously incurable cases. However, the effective management of imm…
Preview only. Read the full abstract at the source